1-21577448-G-T
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM5PP2PP3_StrongPP5_Very_Strong
The NM_000478.6(ALPL):c.1375G>T(p.Val459Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,459,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V459A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000478.6 missense
Scores
Clinical Significance
Conservation
Publications
- adult hypophosphatasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
- childhood hypophosphatasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
- hypophosphatasiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
- infantile hypophosphatasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
- odontohypophosphatasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- perinatal lethal hypophosphatasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALPL | NM_000478.6 | c.1375G>T | p.Val459Leu | missense_variant | Exon 12 of 12 | ENST00000374840.8 | NP_000469.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALPL | ENST00000374840.8 | c.1375G>T | p.Val459Leu | missense_variant | Exon 12 of 12 | 1 | NM_000478.6 | ENSP00000363973.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1459570Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 726266 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypophosphatasia Pathogenic:2
Variant summary: ALPL c.1375G>T (p.Val459Leu) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 244600 control chromosomes. c.1375G>T has been observed in at-least one heterozygous individual with odontohypophosphatasia and at-least one compound heterozygous individual with perinatal lethal Hypophosphatasia who carried a pathogenic variant in trans (example: Fauvert_2009, Del Angel_2020). These data indicate that the variant is associated with disease. A different variant affecting the same codon has been classified as pathogenic by our lab (c.1375G>A, p.Val459Met), supporting the critical relevance of codon 459 to ALPL protein function. At least one publication reports experimental evidence evaluating an impact on protein function. Specifically, measurement of in vitro alkaline phosphatase activity in COS-7 cells transfected with mutated cDNA with the variant of interest demonstrated a 0% (% wild type) residual alkaline phosphatase activity level (example: Fauvert_2009). The following publications have been ascertained in the context of this evaluation (PMID: 32160374, 19500388, 32973344). ClinVar contains an entry for this variant (Variation ID: 558598). Based on the evidence outlined above, the variant was classified as as pathogenic for AD and AR Hypophosphatasia.
ALPL c.1375G>T is a missense variant that changes the amino acid at residue 459 from Valine to Leucine. This variant has been observed in at least one proband affected with hypophosphatasia (PMID:19500388;32160374). At least one functional study has demonstrated a substantial alteration in protein function relative to the wild-type (PMID:19500388). It is absent or not present at a significant frequency in gnomAD. In silico models agree that this variant is possibly or probably damaging. In conclusion, we classify ALPL p.Val459Leu (c.1375G>T) as a pathogenic variant.
not provided Pathogenic:1
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 459 of the ALPL protein (p.Val459Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant hypophosphatasia and/or hypophosphatasia (PMID: 19500388; Invitae). ClinVar contains an entry for this variant (Variation ID: 558598). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALPL protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ALPL function (PMID: 19500388). This variant disrupts the p.Val459 amino acid residue in ALPL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11438998, 27699270, 31707452). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Infantile hypophosphatasia Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at